Mechanisms of neointima formation - Lessons from experimental models

Vascular Medicine

Volumn 2, Issue 3, 1997, Pages 179-189

  De Meyer, Guido R Y ^a   Bult, Hidde ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Balloon angioplasty; Intimal thickening; Neointima models; Restenosis; Smooth muscle cell migration; Thrombus formation

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN; ANTISENSE OLIGONUCLEOTIDE; BASIC FIBROBLAST GROWTH FACTOR; CILAZAPRIL; DILTIAZEM; DIPYRIDAMOLE; ENDOTHELIN; ENOXAPARIN; HEPARIN; HIRUDIN; MATRIX METALLOPROTEINASE; MEVINOLIN; MITOGENIC AGENT; NIFEDIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLATELET DERIVED GROWTH FACTOR; PREDNISOLONE; SILICONE; TRAPIDIL; VAPIPROST; VERAPAMIL; VON WILLEBRAND FACTOR; WARFARIN;

ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CELL DAMAGE; CELL MIGRATION; COMMON CAROTID ARTERY; ENDOTHELIUM CELL; GENE TRANSFER; HUMAN; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; RESTENOSIS; THROMBUS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0030810035     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X9700200304     Document Type: Article

References (126)

1. Stary HC, Blankenhorn DH, Chandler AB et al A definition of the intima of human arteries and of its atherosclerosis-prone regions. Circulaton 1992; 85: 391-405.
2. Gittenberger-de Groot AC, van Ertbruggen I, Moulaert AJMG, Harinck E. The ductus arteriosus in the preterm infant: histologic and clinical observations. J Pediatr 1980; 96: 88-93.
3. Gittenberger-de Groot AC, Strengers JLM, Mentink M, Poelmann RE, Patterson DF Histologic studies on normal and persistent ductus arteriosus in the dog. J Am Coll Cardiol 1985; 6: 394-404.
4. De Reeder EG, Poelmann RE, van Munsteren JC, Patterson DF, Gittenberger-de Groot AC. Hyaluronic acid accumulation and endothelial cell detachment in intimal thickening of the vessel wall. Am J Pathol 1988; 132: 574-85.
5. Curner JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty have we been aiming at the wrong target? J Am Coll Cardiol 1995; 25: 516-20.
6. Bauriedel G, Kandolf R, Welsch U, Höfling B. Mechanismen der Restenosierung nach Angioplastie. Z. Kardiol 1994; 83 (suppl 4): 31-41.
7. Schwartz RS, Holmes DR Jr, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992; 20: 1284-93.
8. Jackson CL. Animal models of restenosis. Trends Cardiovasc Med 1994; 4: 122-30.
9. Fingerle J, Au YPT, Clowes AW, Reidy MA. Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis 1990; 10: 1082-87.
10. Betz E, Schlote W. Responses of vessel walls to chronically applied electrical stimuli. Basic Res Cardiol 1979; 74: 10-20.
11. Banai S, Shou M, Correa R et al. Rabbit ear model of injury-induced arterial smooth muscle cell proliferation. Circ Res 1991, 69: 748-56.
12. Richardson M, Hatton MWC, Buchanan MR, Moore S. Wound healing in the media of the normolipemic rabbit carotid artery injured by air drying or by balloon catheter de-endothelialization. Am J Pathol 1990; 137: 1453-65.
13. Booth RFG, Martin JF, Honey AC, Hassall DG, Beesley JE, Moncada S. Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis 1989; 76: 257-69.
14. De Meyer GRY, Bult H, van Hoydonck A-E, Jordaens FH, Buyssens N, Herman AG. Neo-intima formation impairs endothelial muscarinic receptors while enhancing prostacyclin mediated responses in the rabbit carotid artery Circ Res 1991; 68: 1669-80.
15. Kockx MM, De Meyer GRY, Jacob WA, Bult H, Herman AG Triphasic sequence of neointimal formation in the cuffed carotid artery of the rabbit. Arterioscler Thromb 1992; 12: 1447-57.
16. Soma MR, Donetti E, Parolini C et al HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits. Arterioscler Thromb 1993; 13: 571-78
17. Arthur JF, Dusting GJ. Selective endothelial dysfunction in early atheroma like lesions in the rabbit. Coron Artery Dis 1992; 3: 623-29.
18. Schwartz SM, deBlois D, O'Brien ERM. The intima. Soil for atherosclerosis and restenosis. Circ Res 1995; 77: 445-65.
19. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation, Circ Res 1991; 68: 106-13.
20. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial cell. Circ Res 1991; 68; 450-56.
21. 1 during repair of arterial injury J Clin Invest 1991; 88: 904-10.
22. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 1992; 89: 507-11.
23. Hirosumi J, Nomoto A, Ohkubo Y et al. Inflammatory responses in cuff-induced atherosclerosis in rabbits. Atherosclerosis 1987, 64: 243-54.
24. Hagihara H, Nomoto A, Mutoh S, Yamaguchi I, Ono T. Role of inflammatory responses in initiation of atherosclerosis: effects of antiinflammatory drugs on cuff-induced leukocyte accumulation and intimal thickening of rabbit carotid artery. Atherosclerosis 1991; 91: 107-16.
25. Kockx MM, De Meyer GRY, Andries LJ, Bult H, Jacob WA, Herman AG. The endothelium during cuff-induced neointima formation in the rabbit carotid artery Arterioscler Thromb 1993; 13: 1874-84.
26. Scott TM, Honey AC, Martin JF, Booth RFG. Penvascular innervation is lost in experimental atherosclerosis. Cardioscience 1992; 3: 145-53.
27. Yong AC, Townley G, Boyd GW. Haemodynamic changes in the Moncada model of atherosclerosis. Clin Exp Pharmacol Physiol 1992; 19: 339-42.
28. Siegfried MR, Carey C, Ma X-L, Lefer AM Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am J Physiol 1992; 263: H771-H777.
29. De Meyer GRY, van Put DJM, Kockx MM et al. Possible mechanisms of collar-induced intimal thickening. Arterioscler Thromb Vasc Biol 1997 (in press).
30. Casscells W, Engler D, Willerson JT. Mechanisms of restenosis. Texas Heart Inst J 1994; 21: 68-77.
31. Nikkari ST, Clowes AW. Restenosis after vascular reconstruction. Ann Med 1994; 26: 95-100.
32. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Atari Acad Sci USA 1991; 88: 3739-43.
33. Olson NE, Chao S, Lindner V, Reidy M. Intimal smooth muscle cell proliferation after balloon catheter injury. Am J Parthol 1992; 140: 1017-23.
34. Gajdusek CM, Carbon S. Injury-induced release of basic fibroblast growth factor from bovine aortic endothelium. J Cell Physiol 1989; 139: 570-79.
35. Fingerle J, Muller RM, Kuhn H, Pech M, Baumgartner HR. Mechanism of inhibition of neointimal formation by the angiotensin-converting enzyme inhibitor cilazapril. A study in balloon catheter-injured rat carotid arteries Arterioscler Thromb Vasc Biol 1995; 15: 1945-50.
36. van Belle E, Bauters C, Wernert N et al. Angiotensin converting enzyme inhibition prevents proto-oncogene expression in the vascular wall after injury. J Hypertension 1995, 13: 105-12.
37. Kim S, Kawamura M, Wanibuch H et al. Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery. Circulation 1995; 92: 88-95.
38. Fishel RS, Thourani V, Eisenberg SJ et al. Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. Possible mediator of the response to vascular injury J Clin Invest 1995; 95: 377-87.
39. Hanson SR, Powell JS, Dodson T et al. Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension 1991; 18 (suppl II): II-70-II-76.
40. Huber KC, Schwartz RS, Edwards WD et al. Effects of angiotensin converting enzyme inhibition on neointimal proliferation in a porcine coronary injury model. Am Heart J 1993; 125: 695-701.
41. De Meyer GRY, Bult H, Kockx MM, Herman AG. Effect of angiotensin converting enzyme inhibition on neo-intima formation in the rabbit collared carotid artery. J Cardiovasc Pharmacol 1995; 26: 614-20.
42. Wang X, Douglas SA, Louden C, Vickery-Clark LM, Feuerstein GZ, Ohlstein EH. Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat. Circ Res 1996; 78: 322-28.
43. Weber H, Webb ML, Serafino R et al. Endothelin-1 and angiotensin-II stimulate delayed mitogenesis, in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms. Mol Endocrinol 1994; 8: 148-58.
44. Sullivan TR Jr, Karas RH, Aronovitz M et al. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 1995; 96: 2482-88.
45. Foegh ML, Asotra S, Howell MH, Ramwell PW. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg 1994; 19: 722-26.
46. Foegh ML, Zhao Y, Farhat M, Ramwell PW. Oestradiol inhibition of vascular myointimal proliferation following immune, chemical and mechanical injury. Ciba Found Symp 1995; 191: 139-49.
47. Chen SJ, Li H, Durand J, Oparil S, Chen YF. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation 1996; 93: 577-84.
48. Shi Y, Fard A, Galeo A et al Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury. Circulation 1994; 90: 944-51.
49. Scott-Burden T, Vanhoutte PM. Regulation of smooth muscle cell growth by endothelium-derived factors. Texas Heart Inst J 1994; 21: 91-97.
50. Niimi Y, Azuma H, Hirakawa K. Repeated endothelial removal augments intimal thickening and attenuates EDRF release. Am J Physiol 1994, 266: H1348-H1356.
51. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-77
52. Schini VB, Busse R, Vanhoutte PM. Inducible nitric oxide synthase in vascular smooth muscle. Drug Res 1994; 44: 432-35.
53. Dubey RK, Jackson EK, Lüscher TF. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. J Clin invest 1995; 96: 141-49.
54. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 1996; 78: 225-30.
55. Guo JP, Panday MM, Consigny PM, Lefer AM. Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury. Am J Physiol 1995; 269: H1122-H1131.
56. Farhy RD, Carretero OA, Ho K-L, Scicli AG. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res 1993; 72: 1202-10.
57. von der Leyen HE, Gibbons GH, Morishita R et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 1995; 92: 1137-41.
58. De Meyer GRY, Bult H, Üstünes L, Kockx MM, Feelisch M, Herman AG. Effect of nitric oxide donors on neointima formation and vascular reactivity in the collared carotid artery of rabbits. J Cardiovasc Pharmacol 1995; 26: 272-79.
59. Hassid A, Arabshahi H, Bourcier T, Dhaunsi GS, Matthews C. Nitric oxide selectively amplifies FGF-2-induced mitogenesis in primary rat aortic smooth muscle cells. Am J Physiol 1994; 267: H1040-H1048.
60. Prescott MF, McBride CK, Court M. Development of intimal lesions after leukocyte migration into the vascular wall. Am J Pathol 1989; 135: 835-46.
61. van Put DJM, van Hove CE, De Meyer GRY, Wuyts F, Herman AG, Bult H. Dexamethasone influences intimal thickening and vascular reactivity in the rabbit collared carotid artery. Eur J Pharmacol 1995; 294: 753-61.
62. Kling D, Fingerle J, Harlan JM, Lobb RR, Lang F. Mononuclear leukocytes invade rabbit arterial intima during thickening formation via CD18- and VLA-4-dependent mechanisms and stimulate smooth muscle migration. Circ Res 1995; 77: 1121-28.
63. Tracey WR, Peach MJ. Differential muscarinic receptor mRNA expression by freshly isolated and cultured bovine aortic endothelial cells. Circ Res 1992; 70: 234-40.
64. Bult H, De Meyer GRY, van Put DJM et al. Polymorphonuclear leucocytes and intimal proliferation in the rabbit carotid artery. Br J Pharmacol 1995; 114: 210P [Abstract].
65. Jackson CL, Raines EW, Ross R, Reidy MA. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb 1993; 13: 1218-26.
66. Koyama N, Hart CE, Clowes AW. Different functions of the platelet-derived growth factor-α and -β receptors for the migration and proliferation of cultured baboon smooth muscle cells. Circ Res 1994; 75: 682-91.
67. Lindner V, Giachelli CM, Schwartz SM, Reidy MA. A subpopulation of smooth muscle cells in injured rat arteries expresses platelet-derived growth factor-B chain mRNA. Circ Res 1995; 76: 951-57.
68. Abedi H, Zachary I. Signalling mechanisms in the regulation of vascular cell migration. Cardiovasc Res 1995; 30: 544-56.
69. Pompili VJ, Gordon D, San H et al. Expression and function of a recombinant PDGF B gene in porcine arteries. Arterioscler Thromb Vasc Biol 1995; 15: 2254-64.
70. Kanzaki T, Tamura K, Takahashi K et al. In vivo effect of TGF-beta 1. Enhanced intimal thickening by administration of TGF-beta 1 in rabbit arteries injured with a balloon catheter. Arterioscler Thromb Vasc Biol 1995; 15: 1951-57.
71. Slomp J, van Munsteren JC, Poelmann RE, De Reeder EG. Bogers AJ, Gittenberger-de Groot AC. Formation of intimal cushions in the ductus arteriosus as a model for vascular intimal thickening. An immunohistochemical study of changes in extracellular matrix compounds. Atherosclerosis 1992; 93: 25-39.
72. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11-25.
73. Clyman RI, Tannenbaum J, Chen YQ et al. Ductus arteriosus smooth muscle cell migration on collagen: dependence on laminin and its receptors. J Cell Sci 1994; 107, 1007-18.
74. Tijburg P, Kao J, Yan S-D, van Mourik J, Stem D. Von Willebrand Factor antigen II (vWFAgII) links activation of coagulation and the inflammatory response: induction of endothelial tissue factor, and promotion of monocyte and leukocyte migration. Circulation 1992; 86 (suppl I): I-408 [Abstract].
75. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 1994; 75: 539-45.
76. Bendeck MP, Irvin C, Reidy MA. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res 1996, 78: 38-43.
77. Zempo N, Koyama N, Kenagy RD, Lea HJ, Clowes AW. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol 1996, 16; 28-33.
78. Dollery CM, McEwan JR, Henney AM Matrix metalloproteinases and cardiovascular disease. Circ Res 1995; 77: 863-68.
79. More RS, Underwood MJ, Brack MJ, de Bono DP, Gershlick AH. Changes in vessel wall plasminogen activator activity and smooth muscle cell proliferation and activation after arterial injury. Cardiovasc Res 1995; 29: 22-26.
80. 1 receptors in neointima of rat aorta. J Clin Invest 1992; 90: 1707-12.
81. Cercek B, Fishbein MC, Forrester JS, Helfant RH, Fagin JA. Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ Res 1990; 66: 1755-60.
82. Bochaton-Piallat M-L, Gabbiani F, Redard M, Desmoulière A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol 1995; 146: 1059-64.
83. Violaris AG, Melkert R, Herrman JP, Serruys PW. Role of angiographically identifiable thrombus on long-term luminal renarrowing after coronary angioplasty: a quantitative angiographic analysis. Circulation 1996; 93: 889-97.
84. Unterberg C, Sandrock D, Nebendahl K, Buchwald AB. Reduced acute thrombus formation results in decreased neointimal proliferation after coronary angioplasty. J Am Coll Cardiol 1995; 26: 1747-54.
85. Bosmans JM, Kockx MM, Vrints CJ, Bult H, De Meyer GRY, Herman AG. Fibrin(ogen) and von Willebrand factor deposition are associated with intimal thickening after balloon angioplasty of the rabbit carotid artery. Arterioscler Thromb Vasc Biol 1997; 17: 634-45.
86. Shaw LA, Rudin M, Cook NS. Pharmacological inhibition of resteuosis: learning from experience. Trends Pharmacol Sci 1995; 16: 401-404.
87. Völker W, Faber V Aspirin reduces the growth of medial and neointimal thickenings in balloon-injured rat carotid arteries. Stroke 1990; 21 (suppl IV): IV-44-IV-45.
88. Thornton M, Gruentzig AR, Hollman J, King SB III, Douglas JS. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. Circulation 1984; 69: 721-27.
89. Ingerman-Wojenski CM, Silver MJ. Model system to study interaction of platelets with damaged arterial wall. II. Inhibition of smooth muscle cell proliferation by dipyridamole and AH-P719. Exp Mol Pathol 1988; 48: 116-34.
90. Schwarz L, Bourassa MG, Lespérance J et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988; 318: 1714-19.
91. Currier JW, Pow TK, Haudenschild CC, Minihan AC, Faxon DP. Low molecular weight heparin (enoxaparin) reduces restenosis after iliac angioplasty in the hypercholesterolemic rabbit. J Am Coll Cardiol 1991; 17: 118B-125B.
92. Faxon D, Spiro T, Minor S et al. Enoxaparin, a low molecular weight heparin, in the prevention of restenosis after angioplasty: results of a double blind randomized trial. J Am Coll Cardiol 1992; 19: 258A [Abstract].
93. Clowes AW, Clowes MM. Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. Lab Invest 1985; 52: 611-16.
94. Ellis SG, Roubin GS, Wilentz J, Douglas JS Jr, King SB. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 1989; 117: 777-82
95. Sarembock IJ, Gertz SD, Gimple LW, Owen RM, Powers ER, Roberts WC. Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation 1991; 84: 232-43.
96. Webster MWI, Chesebro JH, Grill DE, Badimon JJ, Badimon L, Fuster V. The thrombotic and proliferative response to angioplasty in pigs after deep arterial injury: effect of intravenous thrombin inhibition with hirudin. Circulation 1991; 84 (suppl II): II-580 [Abstract].
97. Mitchell JRA. Clinical aspects of the arachidonic-thromboxane pathway. Br Med Bull 1983; 39: 289-95
98. August D, Tilson MD. Modification of myointimal response to arterial injury: effects of aspirin and warfarin. Surgical Forum 1980; 31: 337-38.
99. Urban P, Buller N, Fox K, Shapiro L, Bayliss J, Rickards A. Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty. Br Heart J 1988; 60: 485-88.
100. Tiell ML, Sussman II, Gordon PB, Saunders RN. Suppression of flbroblast proliferation in vitro and of myointimal hyperplasia in vivo by the triazolopyrimidine, trapidil. Artery 1983; 12: 33-50.
101. Liu MW, Roubin GS, Robinson KA et al. Trapidil in preventing restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation 1990; 81: 1089-93.
102. Okamoto S, Inden M, Setsuda M, Konishi T, Nakano T. Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1992; 123: 1439-44.
103. Maresta A, Balducelli M, Cantini L et al. Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Circulation 1994; 90 2710-15.
104. Popma JJ, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation 1991; 84: 1427-36.
105. 2-receptor blockade A randomized, double-blind, placebo-controlled trial. Circulation 1991; 84: 1568-80.
106. Nomoto A, Hirosumi J, Sekiguchi C, Mutoh S, Yamaguchi I, Aoki H. Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonist. Effect on cuff-induced intimal thickening of rabbit carotid artery. Atherosclerosis 1987; 64: 255-61.
107. O'Keefe JH Jr, McCallister BD, Bateman TM, Kuhnlein DL, Ligon RW, Hartzier GO. Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J Am Coll Cardiol 1992; 19: 1597-600.
108. Jackson CL, Bush RC, Bowyer DE. Mechanism of antiatherogenic action of calcium antagonists. Atherosclerosis 1989; 80: 17-26.
109. Whitworth HB, Roubin GS, Hollman J et al. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty J Am Coll Cardiol 1986; 8: 1271-76.
110. El-Sanadiki M, Cross KS, Mikat EM, Hagen PO. Verapamil therapy reduces intimal hyperplasia in balloon-injured rabbit aorta. Circulation 1987; 76 (suppl 4): IV-314 [Abstract].
111. Hoberg E, Schwarz F, Schömig A et al. Prevention of restenosis by verapamil. The verapamil angioplasty study (VAS). Circulation 1990; 82 (suppl III): III-28 [Abstract].
112. Powell JS, Clozel J-P, Müller RKM et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989; 245: 186-88.
113. Serruys PW, Rutsch W, Danchin N et al. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the Mercator study: a multicenter, randomized, double-blind placebo-controlled trial. Circulation 1992; 86: 100-10.
114. Soma MR, Donetti E, Parolini C et al. HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits. Arterioscler Thromb 1993; 13: 571-78.
115. Sahni R, Maniet AR, Voci G, Banka VS. Prevention of restenosis by lovastatin after successful coronary angioplasty. Am Heart J 1991; 121: 1600-608.
116. Voss R, Mueller IR, Matthias FR. Effect of monocytopenia on trauma-induced atherosclerotic lesions in the rabbit ear artery. Exp Mol Pathol 1988; 49: 75-86.
117. Stone GW, Rutherford BD, McConahay DR et al. A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty. Cathet Cardiovasc Diagn 1989; 18: 227-31.
118. Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Leon MB. Intravascular ultrasound comparison of restenotic and de novo coronary artery narrowings. Am J Cardiol 1994; 74: 1278-80.
119. Lafont A, Guzman LA, Whitlow PL, Goormastic M, Cornhill JF, Chisolm GM. Restenosis after experimental angioplasty. Intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res 1995; 76: 996-1002.
120. Lafont A, Durand E, Rahal S et al. Resténose: physiopathologie, remèdes et prévention. Ann Cardiol Angeiol 1995; 44: 349-53.
121. Wong SC, Leon MB. Intracoronary stents. Curr Opin Cardiol 1995; 10: 404-11
122. Guzman LA, Mick MJ, Arnold AM, Forudi F, Whitlow PL. Role of intimal hyperplasia and arterial remodeling after balloon angioplasty. Anerioscler Thromb Vasc Biol 1996; 16: 479-87.
123. Prescott MF, Sawyer WK. ACE inhibition versus angiotensin II, AT1 receptor antagonism: a review of effects on intimal lesion formation in animal models of vascular injury, restenosis, and atherosclerosis. Drug Dev Res 1993; 29: 88-93.
124. Bosmans JM, Bult H, Vrints CJ, Kockx MM, Herman AG. Balloon angioplasty and induction of non-endothelial nitric oxide synthase in rabbit carotid arteries. Eur J Pharmacol 1996; 310: 163-74
125. Haudenschild CC. Restenosis: pathophysiologic considerations. In: Topol EJ ed. Textbook of interventional cardiology. Philadelphia, PA: WB Saunders, 1994: 382-99
126. Autieri MV, Feuerstein GZ, Yue TL, Ohlstein EH, Douglas SA. Use of differential display to identify differentially expressed mRNAs induced by rat carotid artery balloon angioplasty. Lab Invest 1995; 72: 656-61.